Skip to content

Feasibility study of manual based cognitive behavioral therapy for depression conducted by mental health specialists in japan

Feasibility study of manual based cognitive behavioral therapy for depression conducted by mental health specialists in japan - Manual based CBT by mental health specialists (CREC Study)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000012106
Enrollment
30
Registered
2013-10-25
Start date
2012-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Interventions

Sponsors

CREC Study Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Subjects with current DSM-4 Major Depressive Disorder based on SCID-P at screening 2.Subjects with HAMD-17 score>16 at screening 3.Aged 20 years or older, and 65 years or younger at screening 4.Subjects who give full consent in the participation of the study

Exclusion criteria

Exclusion criteria: 1.No alcohol or substance use disorder in 6 months prior to the screening. 2.No history or concurrent manic or psychiatric episode. 3.No other primary DSM-4 Axis1 Disorders at screening. 4.No comorbid of antisocial personality. 5.No serious suicidal ideation at screening. 6.Evidence of unable to participate half or more of the intervention phase. 7.No past treatment of CBT. 8.No organic brain lesions or major cognitive deficits in a year prior to the screening. 9.No sever or unstable medical co-morbidities at screening. 10.Other relevant reason decided by the CREC investigators.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Rating Scale(GRID-HAMD-17) score at 16 week from the baseline will be compared.

Secondary

MeasureTime frame
Remission rate (defined as GRID-HAMD-17<7; QIDS<5), response rate (defined as 50% reduction of baseline HAMD-17 and QIDS), subjective depression (measured with the BDI and QIDS), Quality of life (measured with EQ-5D and SF-36) score at 16 week from the baseline will be compared. Dropout rate and adverse events will also be evaluated.

Countries

Japan

Contacts

Public ContactNoriko Tamura

National Center for Neurology and Psychiatry National Center for Cognitive Behavior Therapy and Research

norikotamura@ncnp.go.jp042-341-2711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026